HOME › DRUGS › AMIVANTAMAB
ACTIVE SUBSTANCE / INN

AMIVANTAMAB

Brand name(s): Rybrevant
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Amivantamab
REGULATORS
EMA
SPONSORS / MAH
Janssen-Cilag International N.V.   
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RybrevantJanssen-Cilag International N.V.   Authorised09/12/2021Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON AMIVANTAMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →